SUNDAY, JUNE 24, 2018

Contract awarded to PositiveID Corp. to expand on leading edge BioThreat detection

While the increased visibility of the Ebola virus continues, PositiveID Corp. (PSID) and their partner ENSCO Inc. have been awarded a SenseNet contract with the goal of building on existing infrastructure to deliver faster, less expensive and leading edge BioThreat detection systems.

Under the contract, awarded by the U.S. Department of the Interior on behalf of the U.S. Department of Homeland Security Science & Technology Directorate, PSID will use their Firefly Dx system, a point-of-need system designed to deliver molecular diagnostic results using real time polymerase chain reaction chemistry to provide an added level of security.

The Firefly technology leads to more rapid and effective methods of treating bio-threats by providing a diagnostic result in less than 20 minutes, while lab tests can take two to four hours. ENSCO will ensure that the systems integration is successful.

PSID is based in Delray Beach, Florida, and Pleasanton, California.

With the bio-detection market surging after threats like anthrax, ricin, SARS, H1N1, Middle East and North Korean biological weapons and now Ebola, Homeland Security Research Corp. estimates that the bio-detection market will grow to $5.6 billion by 2016.

Organizations in this Story


Want to get notified whenever we write about PharmiWeb ?
Next time we write about PharmiWeb, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.